薬物動態
Print ISSN : 0916-1139
A novel anti-ulcer agent (TEI-5103) acting directly on the gastric mucosa from lumen. II: Distribution of TEI-5103 to gastric mucosa in rats
Hirofumi TanabeNoboru YamazakiJun-ichi SatoTsutomu MochizukiKouichiro OkabeTakeo OhbaTatsuyuki Naruchi
著者情報
ジャーナル フリー

1988 年 3 巻 1 号 p. 33-40

詳細
抄録
In the present study, we examined the distribution of TEI-5103 to gastric mucosa, as a target tissue, from the gastric lumen after oral administration of 14C-TEI-5103 to rats at its anti-ulcer dose (200 mg/kg).
When given orally, the radioactivity in gastric mucosa was much higher than that in plasma, unlike after intraduodenal administration. And the radioactivity in gastric mucosa was mostly present as unchanged drug, which was different from that in plasma. The concentration of unchanged drug in the gastric mucosa after oral administration was about 100 times higher than that after intraduodenal dosing. Additionally, radioactivity was observed in plasma after intragastric administration under pylorus ligation, indicating that TEI-5103 is at least absorbed from the gastric lumen.
In conclusion, we demonstrated TEI-5103 penatrated well to gastric mucosa as a target tissue directly from the gastric lumen after oral but not after systemic administration. These results suggest that TEI-5103 exerts its anti-ulcer effect by acting directly on the gastric mucosa when the drug is given orally.
著者関連情報
© The Japanese Society for the Study of Xenobiotics
前の記事 次の記事
feedback
Top